Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Revenue

Rohto Pharmaceutical had revenue of 91.62B JPY in the quarter ending June 30, 2026, with 11.79% growth. This brings the company's total for the last twelve months to 353.39B, up 9.67% year-over-year. In the fiscal year ending March 31, 2026, Rohto Pharmaceutical had annual revenue of 343.73B with 11.37% growth. That makes Rohto Pharmaceutical the 4,616th largest company in the world by revenue and 456th in Japan.

• Revenue (ttm): 353.39B
• Revenue Growth: +9.67%
• P/S Ratio: 1.72
• Revenue / Employee: 38.03M
• Employees: 9,292
• Market Cap: 607.17B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Japan 174.00B 48.9%
• Asia 131.11B 36.8%
• Europe 24.09B 6.8%
• Americas 23.16B 6.5%
• Others 3.69B 1.0%

By Geography

Chart

• Japan 168.42B 49.0%
• Others 124.30B 36.2%
• China 51.01B 14.8%

Fiscal year ended Mar 31, 2026 See the full Rohto Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	343.73B	35.10B	11.37%
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error